NEOGEN CORP
Neogen Corporation (NASDAQ: NEOG) operates as a global developer, manufacturer and marketer of products and services dedicated to food and animal safety. The company's website is www.neogen.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What NEOGEN CORP does
In the company’s own words
Neogen Corporation (NASDAQ: NEOG) operates as a global developer, manufacturer and marketer of products and services dedicated to food and animal safety. The company's website is www.neogen.com.
Neogen operates through two primary reportable segments: Food Safety and Animal Safety. The Food Safety segment develops diagnostic test kits, culture media, and complementary products sold to food and animal feed producers, processors, laboratories and regulatory agencies. These solutions detect foodborne pathogens, spoilage organisms, natural toxins, food allergens and environmental sanitation indicators. Key product lines include tests for natural toxins and allergens, bacterial detection systems, the Molecular Detection System using loop-mediated isothermal amplification technology, Reveal immunoassay products, Petrifilm plating systems, the Soleris system for spoilage organism detection, and Neogen Analytics software-as-a-service offerings for food safety data management.
The Animal Safety segment encompasses veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent and insect control products, and genomics testing services. Notable brands include Ideal and Prima Tech veterinary instruments, NeogenVet animal care products, Ramik and CyKill rodent control solutions, and Prozap insect control products. The segment also operates six genomics laboratories offering DNA genotyping and sequencing services for livestock and companion animals. In March 2026, Neogen announced a definitive agreement to sell its Genomics business to Zoetis Inc. for $160 million.
As of May 31, 2026, Neogen employed 2,636 people worldwide, with 1,346 in North America and 1,290 internationally. The company maintains manufacturing facilities in the United States, United Kingdom, Ireland and Brazil, and provides genomics services across six countries. Neogen maintains direct sales presence in 28 countries outside the United States and operates through a network of distributors in more than 100 countries. International sales represented 51.2 percent of total revenues in fiscal 2026.
The company's growth strategy emphasizes increasing sales of existing products, introducing innovative offerings, expanding international operations and pursuing strategic acquisitions. Neogen was formed as a Michigan corporation in 1981 and completed a significant transaction in September 2022 combining 3M's Food Safety Division with Neogen through a Reverse Morris Trust structure.
Company details
- Sector
- Materials
- Industry
- Chemicals
- Headquarters
- LANSING, MI
- Fiscal year end
- May
- CIK
- 711377
- SIC
- 2835
Financial performance, year by year
Fiscal 2012–2026 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns NEOGEN CORP — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · NEOGEN CORP’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do NEOGEN CORP and its peers compare on margins and cash generation over ten years?”
- “Where did five years of NEOGEN CORP's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in NEOGEN CORP's last four quarterly filings that the numbers alone won't show?”